Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Goodier

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
European Journal of Immunology|April 22, 2011
Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cellsNick C Matthews, Martin R Goodier, Rebecca C Robey, et al.
Viral Immunology|June 30, 2012
PD-1 expression on natural killer cells and CD8(+) T cells during chronic HIV-1 infectionSonia Norris, Adam Coleman, Leticia Kuri-Cervantes, et al.
Journal of Virology|October 13, 2006
NKG2C+ NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcomaMartin R Goodier, C M Mela, A Steel, et al.
Diabetes/Metabolism Research and Reviews|March 31, 2006
Identical twins discordant for type 1 diabetes show a different pattern of in vitro CD56+ cell activationMartin R Goodier, Niga Nawroly, Huriya Beyan, et al.
Frontiers in Immunology|October 12, 2016
Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell FunctionMartin R Goodier, Chiara Lusa, Sam Sherratt, et al.
AIDS (London, England)|December 4, 2008
Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individualsJohn Ns Gregson, Alan Steel, Mark Bower, et al.
AIDS (London, England)|December 20, 2007
Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individualsChristopher M Mela, Alan Steel, James Lindsay, et al.
Immunology|May 21, 2014
Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigensMatthew J White, Carolyn M Nielsen, Reuben H C McGregor, et al.
AIDS Research and Human Retroviruses|August 28, 2012
Short communication: NKG2C+ NK cells contribute to increases in CD16+CD56- cells in HIV type 1+ individuals with high plasma viral loadJohn N S Gregson, Leticia Kuri-Cervantes, Christopher M Mela, et al.
Blood|August 24, 2014
Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletionsMartin R Goodier, Matthew J White, Alansana Darboe, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
European Journal of Immunology|April 22, 2011
Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cellsNick C Matthews, Martin R Goodier, Rebecca C Robey, et al.
Viral Immunology|June 30, 2012
PD-1 expression on natural killer cells and CD8(+) T cells during chronic HIV-1 infectionSonia Norris, Adam Coleman, Leticia Kuri-Cervantes, et al.
Journal of Virology|October 13, 2006
NKG2C+ NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcomaMartin R Goodier, C M Mela, A Steel, et al.
Diabetes/Metabolism Research and Reviews|March 31, 2006
Identical twins discordant for type 1 diabetes show a different pattern of in vitro CD56+ cell activationMartin R Goodier, Niga Nawroly, Huriya Beyan, et al.
Frontiers in Immunology|October 12, 2016
Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell FunctionMartin R Goodier, Chiara Lusa, Sam Sherratt, et al.
AIDS (London, England)|December 4, 2008
Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individualsJohn Ns Gregson, Alan Steel, Mark Bower, et al.
AIDS (London, England)|December 20, 2007
Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individualsChristopher M Mela, Alan Steel, James Lindsay, et al.
Immunology|May 21, 2014
Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigensMatthew J White, Carolyn M Nielsen, Reuben H C McGregor, et al.
AIDS Research and Human Retroviruses|August 28, 2012
Short communication: NKG2C+ NK cells contribute to increases in CD16+CD56- cells in HIV type 1+ individuals with high plasma viral loadJohn N S Gregson, Leticia Kuri-Cervantes, Christopher M Mela, et al.
Blood|August 24, 2014
Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletionsMartin R Goodier, Matthew J White, Alansana Darboe, et al.
Pageof 4